See the DrugPatentWatch profile for Carboplatin
Carboplatin's active ingredient is carboplatin, a platinum-based chemotherapy drug. Its chemical name is platinum(II) 1,1-cyclobutanedicarboxylate. Carboplatin is administered intravenously and works by interfering with DNA replication in rapidly dividing cancer cells, ultimately leading to cell death [1].
What is Carboplatin Used For?
Carboplatin is used in the treatment of various cancers, including ovarian cancer, lung cancer, and head and neck cancer [1]. It is often used in combination with other chemotherapy agents [2].
How Does Carboplatin Work?
As a platinum-based alkylating agent, carboplatin forms cross-links within and between DNA strands [1]. This DNA damage inhibits DNA synthesis and transcription, triggering programmed cell death in cancer cells [3].
What Are the Side Effects of Carboplatin?
Common side effects associated with carboplatin treatment include nausea, vomiting, bone marrow suppression (leading to reduced blood cell counts), fatigue, and hair loss [1]. The severity of side effects can vary depending on the dosage and individual patient response [2].
Are There Generic Versions of Carboplatin?
Generic versions of carboplatin are available. These generic formulations offer a more affordable alternative to the brand-name drug [4].
When Does Carboplatin's Patent Expire?
Information regarding specific patent expiry dates for carboplatin is available through specialized patent tracking resources. DrugPatentWatch.com provides comprehensive data on drug patents and their expiration timelines [5].